chrisvoncsefalvay/vaers-outcomes huggingface dataset:
4/29/21: HAD BLURRED VISION (ALL DAY UNTIL MORNING OF NEXT DAY) + PRESSURE IN HEAD (ALL DAY INTO EVENING OF NEXT DAY) ABOUT 40 MINUTES AFTER RECEIVING VACCINE. 4/29/21: EVER SINCE VACCINATION, EXPERIENCING EXCESSIVE THIRST. ONGOING 5/1/21: PATIENT DESCRIBED SYMPTOM AS SKULL BONE PAIN (TENDER SCALP WHEN TOUCHED) UNTIL 5/5/21 5/3/21: ONGLING BLADDER IRRITATION. NO BLOOD IN URINE, BUT SOME SPOTTING (~2TSP) ON PADDING 5/17/21 . NO BLOOD PRESENT SINCE 5/4/21 MORNING: LYMPH NODE SWOLLEN UNDER THE LEFT ARM (INJECTION WAS IN RIGHT ARM). SIZE OF A TENNIS BALL, VERY PAINFUL, AND PAIN RADIATED TO AROUND THE LEFT BREAST AREA. PAIN LASTED UNTIL THE AFTERNOON OF 5/6/21. 5/9/21: BLOOD CLOT IN LEFT LEG REACTIVATED IN THE MORNING, ACCOMPANIED BY EXTREME PAIN, SWELLING, WARM TO THE TOUCH. PAIN AND SWELLING HAS BEEN MINIMAL BEGINNING 5/24/21, AND HAS NOT BEEN AS WARM TO THE TOUCH AS IT HAS BEEN.  TREATMENTS: TOOK IBUPROFEN AND TYLENOL AS NEEDED FOR PAIN.  USED ARNICA GEL ON THE ARM AT THE INJECTION SITE + MASSAGE+ CONSTANT MOVEMENT FOR PAIN/STIFFNESS.  USED ARNICA GEL ALSO ON LYMPH NODE UNDER LEFT ARM ELEVATED CLOTTED LEG AND STAYED ACTIVE TO OPTIMIZE BLOOD FLOW, USED LIGHTLY HEATED PAD TO EASE THE LEG PAIN
Malaise, anorexia, SOB on mild exertion, asthenia - arrhythmia (? PVC). Sx on day 1 and 2, began to decrease on day 3 and by day 6 was nl.  Started 1 d after injection, lasted 5 d.
Took Vivotif two days in a row; Spontaneous report received on 27FEB2020.  A pharmacist reported that a female consumer "took Vivotif two days in a row" (PT: Inappropriate schedule of product administration). She was receiving Vivotif for immunisation. She took the first and second dose of Vivotif on 24FEB2020 and 25FEB2020 respectively. Action taken with Vivotif with respect to the reported event was not applicable. The outcome of the reported event was unknown.  Company Comment: A consumer took first and second dose of Vivotif two days in a row (Inappropriate schedule of product administration) instead of taking it every other day. Considering the nature of the event, the causality of Inappropriate schedule of product administration is assessed as not applicable to Vivotif.; Sender's Comments: A consumer took first and second dose of Vivotif two days in a row (Inappropriate schedule of product administration) instead of taking it every other day. Considering the nature of the event, the causality of Inappropriate schedule of product administration is assessed as not applicable to Vivotif.
Bilateral posterior lower leg pain since after performing numerous sprinting/lower leg exercises on 14 October 2021.  Moderate tenderness over gastrocnemius muscles bilaterally, no significant swelling noted.  DP/PT pulses 2+ bilaterally, cap refill less than 2 seconds, SILT distally.  No evidence of compartment syndrome.  Received second coronavirus vaccination on 13 October 2021 concerned is causing current symptoms.
Intradermal vaccine injection given to left forearm and no wheal formed. Repeat injection of vaccine given to back of left arm subcutaneous successfully.
Redness, swelling below injection site.  Itching during the night but not now.
This spontaneous report as received from a physician refers to unspecified number of patients of unknown age. On an unknown date the patients were vaccinated with PNEUMOVAX 23 (lot# unknown, 0.5ml) intramuscularly. The reporter reported that PNEUMOVAX 23 were exposed to a lowest temperature of 32F for a total of 1 hour over "four different occasions" and the improperly stored PNEUMOVAX 23 were administered to an unspecified amount of patients. No adverse effect was reported. This is one of several reports received from the same reporter. Additional information has been requested.
Headache; Fatigue; This is a spontaneous report from a non-contactable consumer (patient). This 34-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration, administered in left arm on 09Apr2021 (Lot Number: EP6955) as single dose for COVID-19 immunization.  Medical history included Pencillin allergy. The patient's concomitant medication was none.  The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EP6955) on left arm on 19Mar2021 (at age of 34-year-old) for covid-19 immunization, took codeine and experienced allergies.  The patient experienced headache and fatigue on 10Apr2021.  The patient had no covid prior vaccination, and no covid tested post vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. There was no treatment received for the adverse event. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The outcome of event headache was recovered on 12Apr2021, of event fatigue was recovered on an unspecified date.  No follow-up attempts are needed. No further information is expected.
left posterior thigh,  Red whelp like surface softball size area with a slight itch.  Home treatment Neosporin  Antibiotic,  I started treatment today 1/29/2021   because I couldn't reach my PCP , I have no outcome to report
Information has been received from a physician, via a company representative, concerning an approximately 15 year old female patient, who was vaccinated (date and dose not specified) with the second dose of Gardasil.  There was no concomitant medication.  The physician reported that after the vaccine was administered, the patient had a fever that lasted for 24 hours.  The patient sought unspecified medical attention.  Additional information has been requested.
patient reported not having felt faint before with vaccines and no problems in the past. after received vaccine said was ok and moved to waiting chair for 15 minutes. a few minutes later (while she was sitting) she passed out and hit her face on the floor.  her glasses cut her cheek. 911 was called and they evaluated patient. unsure whether took her to the hospital but she said she was not going to go.
increasing pulse; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the parent.  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: HEART RATE INCREASED (non-serious), outcome "unknown", described as "increasing pulse". Relevant laboratory tests and procedures are available in the appropriate section.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Patient was given 6month- 4yrs dose instead of 5yrs dose. Patient did not have any reaction.
Pt. states that after receiving the 1st dose of Shingrix 09/17/2021, started experiencing symptoms 09/20/2021 of Rash on the shin spreading throughout the body lasting 20r3 days then go away  Self-Treated with Benadryl cream, Primary communications recommendation treating with Benadryl. Still experiencing symptoms.
injection site swelled slightly; tingling confined to my chin and the bottom of my face; Headache; severe pain at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (tingling confined to my chin and the bottom of my face), HEADACHE (Headache), INJECTION SITE PAIN (severe pain at the injection site) and INJECTION SITE SWELLING (injection site swelled slightly) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. C14C21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 03-May-2021 at 12:30 PM, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Apr-2021, the patient experienced PARAESTHESIA (tingling confined to my chin and the bottom of my face), HEADACHE (Headache) and INJECTION SITE PAIN (severe pain at the injection site). On an unknown date, the patient experienced INJECTION SITE SWELLING (injection site swelled slightly). On 08-Apr-2021, PARAESTHESIA (tingling confined to my chin and the bottom of my face) and HEADACHE (Headache) had resolved. On 09-May-2021, INJECTION SITE PAIN (severe pain at the injection site) had resolved. At the time of the report, INJECTION SITE SWELLING (injection site swelled slightly) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-068481 (Patient Link).   Reporter did not allow further contact
Patient noticed swollen lymph nodes on neck by 9pm on 05/15/21. Fever, chills, and generalized weakness  followed the next day. By 5/17/21,  patient has developed an   intractable headache. Patient will plan to see MD 5/18 if possible.
Hip started hurting; my arm swelled up; under my arm swelled up; my breast swelled up; This case was reported by a consumer via interactive digital media and described the occurrence of swelling arm in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   In May 2022, the patient received the 1st dose of Shingles vaccine. On an unknown date, 1 day after receiving Shingles vaccine, the patient experienced swelling arm, swelling, breast swelling and pain in hip. On an unknown date, the outcome of the swelling arm, swelling and breast swelling were recovered/resolved and the outcome of the pain in hip was not recovered/not resolved.   It was unknown if the reporter considered the swelling arm, swelling, breast swelling and pain in hip to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 18-JUN-2022 Reporter's Comments: This case reported by consumer via interactive digital media. The patient self-reported this case. The patient got the shot 3 weeks ago of the reporting day.  The next day her or his arm swelled up.  The next day under his or her arm and breast swelled up.  The third day all the swelling went away but his or her hip started hurting.  The patient did not know if hip was hurting from the shot or something else.  The patient asked that anyone that has taken the shot had anything like this. In 2022, the patient experienced swelling arm, swelling, breast swelling and pain in hip. For swelling and breast swelling were 2 days. For pain in hip were 3 days.. Follow-up would not be possible as no contact details available.
Expired vaccine used; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a 66-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 021B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 ml. On 04-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 04-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant and treatment medications were reported.
Systemic: Allergic: Difficulty Breathing-Medium, Systemic: Allergic: Difficulty Swallowing, Throat Tightness-Medium
pt had pain/swelling at injection site, developed into rash and spread down arm , Pt saw  MD was prescribed topical cream but it made the  itching worse. Pt stated rash down arm has resolved  but swelling at injection site has , spread and now have rash developed on side of stomach.
Chills- night of vaccine all the way through the next day 2/13 Muscle aches & exhaustion- 2/13/21 lasted all day for one day. Required extra sleep + acetaminophen & ibuprofen  Hives- Woke up 2/14 will small itchy patches all over the body (shoulders, back, stomach, legs, hands, feet). Took benadryl for treatment. Still  itching all day 2/15/21 Sharp chest pain 2/14. Pain started halfway through the day and throughout the night. OTC pain medication had no effect. Disappeared after sleeping and waking up on Monday 2/15 Swollen lymph node in the left armpit (vaccine arm)- slight pain/tenderness. Started 2/14 in the morning. Still slightly tender as of end of the day 2/15
sore arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (sore arm) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included UBIDECARENONE (COQ-10) and COLECALCIFEROL (VITAMIN D3) for an unknown indication.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (sore arm). At the time of the report, VACCINATION SITE PAIN (sore arm) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No concomitant medications was reported. No treatment drug details was reported.   This case was linked to MOD-2021-374377, MOD-2021-374385 (Patient Link).
Could not see; Blurred vision in the left eye; This is a spontaneous report from a contactable consumer (patient). A 53-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), dose 2 via an unspecified route of administration, administered in Arm Left on 15Apr2021 at 16:15 (Batch/Lot Number: EWU161) as DOSE 2, SINGLE for COVID-19 immunization. Medical history was reported as none. The patient did not have any allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medication included ibuprofen (ADVIL) taken for an unspecified indication, start and stop date were not reported. The patient did not receive other vaccinations within four weeks prior to COVID vaccine. The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), dose 1 in the left arm on 25Mar2021 at 16:00 (Batch/Lot Number: ER8727) as DOSE 1, SINGLE for COVID-19 immunization. On 16Apr2021 at 04:30, the patient experienced blurred vision in the left eye; woke up 13 hours after the shot and had foggy vision but not bad; got worse throughout the day; by 24 hours after the shot, complete white out in left eye; could not see. The patient did not receive any treatment for the events. The clinical outcome of the blindness and vision blurred was recovered on 17Apr2021 (by 27 hours started to see improvement; woke up 37 hours after shot with vision back). It was reported that since the vaccination, the patient had not been tested for COVID-19.
Extremely sore arm, severe headache lasting 10 hours then less severe another 3 hours. I was not able to get out of the bed. Migraine medicines (Nurtec and Maxalt) did not touch the headache. I almost went to the ER it was so bad. My doctor said to take Tylenol. I had already taken Ibuprofen 400  mg around 5 p.m. before the doctor's nurse called back and that is the only thing that helped somewhat. Today, 4/30/21, I still have some breakthrough headaches, but not keeping me in the bed.
12hrs after shot, uncontrollable shaking from roughly 10pm-4am with some rest periods. Sore back also occurred.  The next morning, no shaking but developed chest pain, mild lightheadedness, shortness of breath and sore back shoulder. 4 days later, still having some chest pain, mild lightheadedness, shortness of breath and sore back shoulder
Pt recv vax on 3/3/98; on 3/4/98 pt exp rapid pulse/breathing, chills, shakey hands, fever (99-100), neck/back pain & diarrhea; 3/6/98 pt exp hives; tx=blowing in a bag, Tylenol & Benadryl
Father stated onset induration, erythema, warmth, edema began same day of administration, increasing in intensity. On 4/17/16, he took son to local ER. KEFLEX, oral steroid, started. On 4/18/16, he saw PCP who added steroid topical cream to other meds.
Soreness in his arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Soreness in his arm) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M21A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Mar-2021, the patient experienced PAIN IN EXTREMITY (Soreness in his arm). At the time of the report, PAIN IN EXTREMITY (Soreness in his arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided. Treatment medications were unknown.
1430 Administered GARDASIL IM to LA then pt immediately received Tdap IM to RA at which time pt had syncopal episode. Syncopal episode lasted approx 1 min; able to arouse pt with verbal stimulation. Assisted pt to bed and juice given. VS B/P 106/60 P 90 R 16 T 97 degrees O2 Sat 95% RA. MOC denies any medical conditions or hx adverse reaction with prior vaccinations. After 30 min. pt reports feeling - ok; denies any vertigo, lightheadedness. VIS given for HPV and Tdap. Instructed to go to ER with any acute changes; MOC verbalized understanding.
Scabs and red itchy skin on scalp. Recurring itchy red dry flakey patches of dry skin on face.
I had a fever, achy joints and body for just over 24 hours after receiving the vaccine on Monday 11/22/21. That Friday 11/26/21, I developed hives all over my body. The hives only go away if I consistently take benadryl. After 5 days of the hives I went to my doctors and was prescribed Triamcinolone cream to help with the hives.
This spontaneous report was received from an office manager refers to multiple unspecified patients of unknown gender and age. Information regarding the patients' medical history, concurrent conditions, drug reactions/allergies and concomitant therapy were not provided. Reporter stated that on unknown dates, the patients may have been vaccinated with improperly stored doses of GARDASIL 9 (lot # M003659, expiry date: 20-SEP-2017; lot # L043213, expiry date: 28-AUG-2017; lot # L043214, expiry date: 30-AUG-2017). Reporter mentioned that the vaccine was exposed to 31.8 F for 62 hours. A data logger was used to record temperatures. No adverse effects were reported. This is one of the two reports received from the same reporter. Additional information has been requested.
This spontaneous case reported by a patient family member or friend, describes the occurrence of COVID-19 (positive for COVID-19) in a 50-year-old male patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 038K20A) for COVID-19 immunization. No medical history reported. On Mar 27, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On Apr 21, 2021, patient had COVID-19 (positive for COVID-19). At the time of the report, COVID-19 (positive for COVID-19): not resolved. The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: unknown. No concomitant medications reported. The patient got sick and went to the emergency department on Apr 21, 2021 to be tested for COVID-19. Sent home same day. Reporter did not allow further contact.
Woke up early on May 11 with a blinded headache worst than a migrane, had numbness and tingling on left side of face and leg , had no balance can't walk without assistance and developed high blood  pressure, went to dr
On the evening that I received the vaccine, the right side of my body went numb. Then over the course of the next two weeks, I developed muscle fatigue, shakiness, tremors in my fingers, brain fog, and dizziness. I've been hoping the symptoms would go away with time, but it is more than three months later and I am still dealing with all of the symptoms.
Dizziness with Pt blurring of vision after GARDASIL. Few minutes later. She was short of breath > Briefly.
According to the lot# pt was given PCV 15 but supposed to get HPV. NO adverse reactions noted
Pfizer vaccine was diluted with Bacteriostatic NS 0.9% which is not recommended for use with Pfizer. CDC recommendations are to repeat affected dose. Pt was notified, all questions answered. Pt repeated dose on 9/14/21. No s/s reported by pt.
Pain in lateral shoulder, progressing to inability to abduct arm past 40 degrees. No local reaction noted. No swelling or bruising. No pain at time of injection. Has been worsening since. Now all rom is limited. Did not respond to steroids orally. Has been referred for PT.
FEET ICE COLD; CHILLS; This spontaneous report received from a patient concerned a 69 year old male. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: 1805031 expiry: 05-SEP-2021) dose was not reported, administered on 24-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 24-MAR-2021, the subject experienced feet ice cold. On 24-MAR-2021, the subject experienced chills. Laboratory data (dates unspecified) included: Body temperature (NR: not provided) Normal. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from chills, and feet ice cold. This report was non-serious.
Red, raised, pruritus rash in area where the vaccine was given.  05/15 patient presented to clinic - rash no longer raised and patient reports rash being less pruritus.  Borders irregular and area approximately 2 inches in diameter.
Numbness and tingling in lips and oropharynx progressing to face; flushing and redness on chest, itching of hands, eyes, neck; nausea and stomach cramping all onset approx 30-40 minutes after vaccine. Treated in the emergency department w/ famotidine 50mg, solumedrol 125 mg, 1L NS. Noted frequent multifocal PVCs and runs of ventricular bigeminy during Emergency Dept evaluation and ongoing intermittent facial tingling and itching. Admitted for overnight observation.